SA PRO
Free Account
Day One Biopharmaceuticals, Inc.DAWNNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
11 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
11100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 5, 2025Piper Sandler
Day One Biopharmaceuticals price target raised to $26 from $25 at Piper Sandler
Target:$26.00
+214.2%from $8.28
Aug 1, 2024Bank of America Securities
Day One Biopharmaceuticals upgraded to Buy from Underperform at BofA
Target:$24.00
+67.7%from $14.31
May 7, 2024H.C. Wainwright
Day One Biopharmaceuticals (DAWN) PT Lowered to $40 at H.C. Wainwright
Target:$40.00
+141.0%from $16.60
Jan 8, 2023Piper Sandler
Day One Biopharmaceuticals price target raised to $45 from $40 at Piper Sandler
Target:$45.00
+110.9%from $21.34
Dec 15, 2022H.C. Wainwright
HC Wainwright & Co. Initiates Coverage On Day One Biopharmaceutical with Buy Rating, Announces Price Target of $35
Target:$35.00
+62.0%from $21.61
Dec 14, 2022Needham
Needham Initiates Coverage On Day One Biopharmaceutical with Buy Rating, Announces Price Target of $40
Target:$40.00
+94.8%from $20.53
Dec 5, 2022Goldman Sachs
Goldman Sachs Initiates Coverage On Day One Biopharmaceutical with Buy Rating, Announces Price Target of $45
Target:$45.00
+107.0%from $21.74
Jun 20, 2022Piper Sandler
Day One Biopharmaceuticals price target raised to $40 from $35 at Piper Sandler
Target:$40.00
+153.3%from $15.79

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance